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https://doi.org/10.1016/j.celrep.2020.107597SUMMARYFibrosis and fat replacement in skeletal muscle are major complications that lead to a loss of mobility in
chronic muscle disorders, such as muscular dystrophy. However, the in vivo properties of adipogenic
stem and precursor cells remain unclear, mainly due to the high cell heterogeneity in skeletal muscles.
Here, we use single-cell RNA sequencing to decomplexify interstitial cell populations in healthy and dystro-
phic skeletal muscles. We identify an interstitial CD142-positive cell population in mice and humans that is
responsible for the inhibition of adipogenesis through GDF10 secretion. Furthermore, we show that the inter-
stitial cell composition is completely altered in muscular dystrophy, with a near absence of CD142-positive
cells. The identification of these adipo-regulatory cells in the skeletal muscle aids our understanding of the
aberrant fat deposition in muscular dystrophy, paving the way for treatments that could counteract degen-
eration in patients with muscular dystrophy.INTRODUCTION
The skeletal muscle exists out of muscle fibers, multinucleated
contractile units that are structured in bundles or fascicles, sur-
rounded by connective tissue, also called the interstitium (Fron-
tera and Ochala, 2015). Upon acute injury, progenitors swiftly
activate their repair mechanisms and completely regenerate
the skeletal muscle in a time span of weeks (Wosczyna and
Rando, 2018). An abundant assembly of cells has been reported
to be involved in this repair process, of which muscle satellite
cells (MuSCs) are the predominant cell type (Sacco et al.,
2008). MuSCs are skeletal muscle stem cells located beneath
the basal lamina of muscle fibers (Mauro, 1961). In homeostatic
conditions, they remain quiescent, although upon injury they
proliferate, differentiate, and fuse into new or existing myofibers
(Feige et al., 2018). Besides MuSCs, fibro/adipogenic progeni-
tors (FAPs) (Joe et al., 2010), mesenchymal progenitors (UezumiThis is an open access article under the CC BY-Net al., 2010), mesoangioblasts (MABs) (Dellavalle et al., 2007),
Pw1+/Pax7+ interstitial cells (PICs) (Mitchell et al., 2010), and
TWIST2+ progenitors (Liu et al., 2017a) have been reported as
stem cell populations that directly or indirectly support myogenic
regeneration. However, the current characterization of these
cells does not suffice, as many of these cell types share overlap-
ping markers and functions.
In chronic injury, regeneration deteriorates, leading to
increased adipogenesis and fibrosis at the expense of the mus-
cle fibers (Hamrick et al., 2016; Mann et al., 2011). This deposi-
tion of fat and extracellular matrix (ECM) leads to progressive
muscle weakening and dysfunction, leading to the loss of ambu-
lation and respiratory complications (Mercuri and Muntoni,
2013). Although the mechanisms of fibrosis in muscular dystro-
phy are generally understood (Joe et al., 2010; Lemos et al.,
2015; Mueller et al., 2016; Uezumi et al., 2011), it is still unclear
how adipogenesis arises in chronic muscle regeneration. FAPsCell Reports 31, 107597, May 5, 2020 ª 2020 The Authors. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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OPEN ACCESSare described as themain players (Joe et al., 2010; Uezumi et al.,
2011), although it has been shown that MuSCs are also able to
participate in adipogenesis (Pasut et al., 2016). Most studies
aimed at understanding muscle adipogenesis through extended
molecular characterization of the resident cell types in physio-
logical and pathological conditions. However, current methods
using bulk-cell populations isolated based on a small set of
surface markers are limited in resolving the heterogeneity,
niche specificity, and complexity of interstitial cell types within
the skeletal muscle (Costamagna et al., 2015; Panne´rec et al.,
2013; Wosczyna and Rando, 2018). Single-cell technology
allows for unbiased characterization of skeletal muscle
cell types as well as their transition from a healthy to a diseased
state.
Despite the wealth of information, it is still not well understood
how cell types in skeletal muscle cope with chronic injury and
how they switch toward an adipogenic phenotype. Importantly,
the cell types that play a role in disease progression are
numerous, and their specific involvements remain controversial.
Here, we combine unbiased single-cell RNA sequencing, exten-
sive cell fate characterization, genetic perturbation, and compu-
tational modeling to comprehensively characterize the alteration
of the interstitial landscape in the skeletal muscle exposed to
chronic injury. Using amousemodel of limb-girdlemuscular dys-
trophy (LGMD) that closely resembles symptoms of human skel-
etal muscle deterioration (Durbeej et al., 2000), we uncovered an
interstitial cell subpopulation in the SCA-1 and PDGFRA-positive
population that controls adipogenesis in the skeletal muscle.
Further analysis showed that this population is also present in
healthy human skeletal muscle and that its presence is drasti-
cally decreased in dystrophic muscle. Upon isolation of this
cell type, we found that this population controls adipogenesis
in a cell-number-dependent manner. Furthermore, dystrophic
muscle showed a reduced number of CD142+ cells compared
to healthy muscle, resulting in an increased adipogenic differen-
tiation of the SCA-1+ cells. Knockdown and overexpression
of Gdf10 showed the importance of this paracrine mediator in
the blocking of adipogenesis by CD142+ cells. Lastly, in vivo
absence of GDF10 led to an increased adipogenesis in the
skeletal muscle that exacerbated upon injury. Overall, our study
identified an adipo-regulatory cell (Areg) in the skeletal muscle
and portrays its importance in sustaining skeletal muscle func-
tion by providing evidence that this population is absent in
chronic muscle injuries, such as LGMD, due to pathological re-
modeling of the interstitial landscape.
RESULTS
Single-Cell RNA Sequencing Resolves the Skeletal
Muscle Interstitial Heterogeneity
To molecularly characterize intra-muscular fat deposition and
the responsible stem cell populations, we performed unbiased
single-cell RNA sequencing (scRNA-seq) from the hindlimbs of
C57Bl6 (healthy) and Sgcb-null (dystrophic) mice (Figures 1A
and S1A). Endothelial and hematopoietic cells were excluded
through sorting of LIN(CD31CD45TER119) cells. After thor-
ough quality control, we retained 256 high-quality cells (Figures
S1B and S1C) and confirmed the effectiveness of our sorting2 Cell Reports 31, 107597, May 5, 2020strategy by showing that all cells were negative for endothelial
and hematopoietic markers (Figure S1D). Clustering resulted in
seven groups that were annotated as MuSCs, smooth muscle
cells (SMCs), Schwann cells, fibroblasts, and three clusters of
interstitial stromal cells (ISCs) (Figures 1B and S1E–S1G). Every
cluster was characterized by the expression of marker genes like
Fmod and Tnmd for fibroblasts (Westergren-Thorsson et al.,
1991; Yamana et al., 2001), Myl9 and Tpm2 for smooth muscle
cells (Dube et al., 2014; Licht et al., 2010), Myf5 and Cd82 for
MuSCs (Alexander et al., 2016; Nervi et al., 1995), Plp1 and
Sox10 for Schwann cells (Kuhlbrodt et al., 1998; Nave et al.,
1987), and the co-expression of Ly6a, Pdgfra, and Cd34 for
ISCs (Figures 1C and 1D; Table S1). Furthermore, we checked
the validity of common marker genes and proposed improved
markers for these populations in the skeletal muscle (Fig-
ure S1H). Checking the top area under the receiving operator
curve (AUROC) showed us that Cd82 and Fgfr4 are better
markers for MuSCs than Desmin and Myf5 (Figure S1H). CD82
has already shown to be an excellent marker for human satellite
cells (Alexander et al., 2016).
The ISCs subclustered into three groups, which demonstrates
the heterogeneity of this population (Figures 1C and 1D). Every
ISC population expressed specific markers, like Ly6c1 and
Cd55 for ISC 1, Gdf10 and Meox2 for ISC 2, and Thbs4 and
Fbln7 for ISC 3. The latter markers were also observed in
the fibroblast population (Figure 1D). ISC 1 had the highest
expression of the stem-cell-related genes Ly6a and Cd34. In
addition, gene set enrichment analysis revealed signaling
pathways, such as transforming growth factor b (TGF-b) and
Wnt, and a high correlation to blood vessels and adipose tissue
(Figures 1D, 1E, and S1I; Table S2). ISC 2 correlated to TGF-b
regulators and Wnt signaling pathways and was linked to
blood vessels (Figure S1I). ISC 3 was highly enriched for
ECM organization and metallopeptidase activity and is linked
to skin tissue (Figure S1I).
Recently, the Tabula Muris Consortium (Schaum et al., 2018)
and Giordani et al. (2019) published scRNA-seq data of mouse
limb muscle based on the 10X Genomics platform. By
comparing sequencing metrics, we found that our dataset
was sequenced with more depth and detected more than dou-
ble the number of genes compared to the other datasets (Fig-
ure S2A). Raw counts were retrieved for the Giordani data
(n = 12,441); therefore, we reannotated the cell types based
on their annotation (Figure S2B). We were able to retrieve all
clusters plus three small unannotated clusters that we named
after their top DE marker (Figure S2C). In addition, the Schaum
data for hindlimb muscles (n = 4,543) were filtered and reana-
lyzed, although here, cluster names were already provided by
the authors (Figure S2D). To compare the validity of our clus-
ters, we measured the percentage of matched cell type
markers (STAR Methods) between our data and the Giordani
(Figure S2E) and Schaum dataset (Figure S2F). Data integration
showed that all datasets smoothly overlapped and no specific
dataset clusters arose (Figure S2G). As all our cell clusters over-
lapped with clusters of the public data (Figure S2H), we could
label all clusters accordingly (Figure S2I). In summary, we per-
formed scRNA-seq on healthy and dystrophic skeletal muscle
and identified five cell types, which were validated in public
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Figure 1. Single-Cell RNA Sequencing Reveals the Cellular Heterogeneity in Healthy and Dystrophic Skeletal Muscle
(A) Schematic diagram showing the isolation of single cells from the hindlimbs of healthy and dystrophic mice with SMART-seq2.
(B) t-SNE plot and k-means clustering of 256 cells from healthy and dystrophic skeletal muscle. Every point represents one cell.
(C and D) Heatmap of k-means clusters with 237 marker genes (C). Bar plot showing the expression level (log-normalized counts) of selected marker genes (D).
(E) Violin plot with median visualizing marker genes for ISC clusters. The expression is shown as log-normalized counts. ***p% 0.001.
(F) Bar plot showing the percentage of ISC clusters in healthy and dystrophic skeletal muscle.
See also Figures S1 and S2 and Tables S1 and S2.
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OPEN ACCESSscRNA-seq data. In addition, we observed a distinction of ISCs
into three clusters.
A Dystrophy-Specific Activated Satellite Cell Cluster
To check how cell types adapt to muscular dystrophy, we exam-
ined whether any clusters were enriched for a specific genotype
(Figures S1J and S1K). The most striking difference between
healthy and dystrophic cells was found in the ISCs. Although
ISC 1 and 2 are mainly present in healthy muscle, ISC 3 domi-nates in dystrophic muscle (Figure 1K). Surprisingly, we did not
find obvious changes in the MuSCs. Nevertheless, when we
clustered MuSCs separately, we found that they group accord-
ing to different differentiation stages (Figure S3A; Table S3).
Despite the limited number of cells (n = 40), we identified a clus-
ter of quiescent and activated MuSCs, as well as myoblasts
through the expression of essential myogenic transcription
factors Pax7,Myf5,Myod1, andMyog and through pseudotem-
poral ordering (Figures S3B and S3C). Furthermore, we foundCell Reports 31, 107597, May 5, 2020 3
Article
ll
OPEN ACCESSa cluster of activated MuSCs that was only present in the
dystrophic muscle. This group of dystrophic activated MuSCs
expressed unique markers, such as Angptl4, Arhgap5, Grsf1,
and Dpysl3 (Figure S3D). Many of these genes are linked to lipid
metabolism and cytoskeletal remodeling (Aryal et al., 2016;
Hinge et al., 2017). We checked these genes in the satellite cell
cluster of the Tabula Muris Consortium dataset and could
confirm that, in healthy satellite cells, these genes are rarely ex-
pressed (Figures S3E and S3F). Nevertheless, additional exper-
iments are necessary to verify whether this population is present
in muscular dystrophy and what its effect is on satellite cell
differentiation.
Projection of Known Interstitial Progenitor Markers
To check the presence of previously identified progenitor
populations, we checked the expression of their key markers in
our clusters: Ly6a for FAP (Joe et al., 2010); Pdgfra for mesen-
chymal progenitors (Uezumi et al., 2010); Alpl for MABs (Della-
valle et al., 2007); and Peg3 or Pw1 for PICs (Mitchell et al.,
2010). Except for Peg3, we found that all markers were located
only within the ISC clusters (Figures 2A and 2B). Ly6awasmainly
expressed in ISC 1, although ISC 2 had a higher expression of
Pdgfra. Furthermore, Alpl was limited to ISC 2 and ISC 3,
although the expression of Peg3 increased from ISC 1 to ISC
3, which could implicate that it plays a more important role in
muscular dystrophy (Figure 2C; Table S3).
Because we could not connect these progenitors to a specific
ISC cluster, we asked whether these cell types are functionally
distinct. Therefore, we sorted MABs as LINALPL+ and FAPs
as LINSCA-1+ cells and subjected them to a co-culture
together with freshly isolated MuSCs to check their myogenic
potential. We found that both MABs and FAPs possess the
ability to fuse withMuSCs (Figure 2D). In addition, because these
progenitors are known to be multipotent, we checked for
adipogenic differentiation potential and did not find any differ-
ences in their potency to differentiate toward adipocytes
(Figure 2E).
Although MABs and FAPs are transcriptionally not as distinct
from each other as previously thought, we nonetheless wanted
to assess the possibility of a hybrid transition phase between
these markers during muscle development. Therefore, we
checked whether MABs could become FAPs by lineage tracing
with a tamoxifen-inducible Cre-lox system under the Alpl pro-
moter (Dellavalle et al., 2007). By fluorescence-activated cell
sorting (FACS) analysis for Alpl-YFP, we showed that the per-
centage of SCA-1 in ALPL+ cells increases over age (Figures
S3G and S3H). This suggests that, upon the development of
the skeletal muscle, there is a tight connection between MABs
and FAPs. In summary, we show that four specific markers for
previously reported progenitor populations—although being ex-
pressed at different levels—are not allocated to a specific cluster
and that MABs and FAPs share similar differentiation potential
in vitro and in vivo.
ISC Dynamics in Muscular Dystrophy
Because ISC 1, ISC 2, and ISC 3 did not specifically relate to
any predefined muscle stem cell population, we wanted to
determine the distinction that exists between these clusters.4 Cell Reports 31, 107597, May 5, 2020A first distinction of heterogeneity was observed in Vcam1
and Tek expression. Although Vcam1 is expressed in ISC 2
and ISC 3, Tek is exclusively expressed in ISC 1 (Figures
S4A and S4B). As this does not explain the difference be-
tween ISC 2 and ISC 3, we selected all cells defined as ISC
1, ISC 2, and ISC 3 and performed clustering after quality con-
trol to get rid of technical variability due to External RNA Con-
trols Consortium (ERCC) levels (Figure S4C). We could find
five clusters, supported by a consensus plot, silhouette plot,
and the stability index (Figures S4D–S4F). All cells maintained
the same annotation that was observed in clustering of all
LIN cells (Figure S4G). We found that ISC 3 consists of three
different subgroups: ISC 3a; ISC 3b; and ISC 3c (Figure 3A).
The ISC 3 clusters expressed variability in ISC 3 markers,
such as Thbs4. Furthermore, specific markers were expressed
per cluster, such as G0s2 for ISC 3a, Ptx3 for ISC 3b, and
Cthrc1 for ISC 3c (Figure 3B; Table S4). The markers PTX3
and CTHRC1 were validated through immunofluorescent
staining of healthy and dystrophic skeletal muscle, observing
a drastic increase of both markers in dystrophic mice (Figures
3C–3F).
Considering that we observed a fractional increase in
expression of specific ISC 3 markers and a smooth transition
in genotype from ISC 1 to ISC 3c (Figure S4H), we wondered
whether the ISC clusters we observed are transitional states.
Therefore, we build single-cell trajectories that show three
branches, each belonging to an ISC type. We can observe
ISC 1, ISC 2, and ISC 3c at the ends of their respective
branches, although ISC 3a and 3b are intermittent (Figure 3G).
Ordering these trajectories in pseudotime showed a conversion
from ISC 1 and ISC 2 to ISC 3a and ISC 3b, with ISC 3c as the
end state (Figure S4I). RNA velocity analysis confirmed the di-
rection from ISC 1 and ISC 2 to ISC 3 (Figure 3H). Through
branched expression analysis modeling (BEAM) analysis,
four-gene cluster could be identified that showed high vari-
ability between these cell states (Figure S4J). Here, several ma-
trix metalloproteases, such as Mmp3 and Mmp14, were found
to be responsible for the transition from ISC1 to ISC3 (Fig-
ure S4K). Combined with a high expression of Timp3 in ISC
1, our data correlated with a recent publication where TIMP3
was shown to repress injury-induced adipogenesis through in-
hibition of MMP14 (Kopinke et al., 2017). In addition, we found
a high expression of Il6 and Arid5b in ISC 3 compared to ISC 1
(Figure S4L). Both genes are important mediators of a muscular
dystrophy phenotype and adipogenesis (Liu et al., 2017b;
Wada et al., 2017). We observed a major remodeling of ISC
clusters between healthy and dystrophic muscle. More specif-
ically, we saw an increase in ISC 3 in dystrophic muscle with
the emergence of ISC 3c, while at the same time, ISC 1 and
ISC 2 are highly reduced but still present (Figure 3I). Further,
Gene Ontology (GO) analysis showed that ISC 3b is enriched
for lipid storage and localization—and in general relates the
most to adipose tissue—although ISC 3c relates to wound
healing and ECM assembly and is highly correlated to skin tis-
sue (Figure S4M; Table S5). However, we would like to highlight
that, in order to confirm our pseudotime results, lineage-tracing
studies should be performed to prove the conversion from ISC
1 to ISC 3.
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Figure 2. Most Interstitial Stem Cell Markers Are Localized in One Large Interstitial Stem Cell Cluster
(A–C) Expression of stem cell marker genes.
(A) t-SNE plot of healthy and dystrophic skeletal muscle. Every point represents one cell. Gene expression is shown as log-normalized counts.
(B) Bar plot of the number of cells per cluster positive for genes shown in (A).
(C) Boxplot per cluster. *p% 0.05; **p% 0.01; ***p% 0.001.
(D) Microscopy images of myogenic differentiation in co-culture with MuSCs and GFP+ MABs and GFP+ FAPs. Myotubes stained with MyHC (red), MABs, FAPs
stained with GFP (green), and nuclei stained with Hoechst 33258 (blue) are shown.
(E) Microscopy images of adipogenic differentiation fromMABs (ALPL+), FAPs (SCA-1+), andMuSCs. Adipocytes are stained with Oil Red O (red) and PERILIPIN-
1 (green), and nuclei are stained with Hoechst 33258 (blue).
(F) Fraction of differentiated cells per population shown in (E) (n = 12). Data are represented as mean ± SEM.
Scale bars, 50 mm. See also Figure S3 and Table S3.
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OPEN ACCESSBecause our scRNA-seq data are made up out of healthy
and dystrophic cells, we wanted to make sure that genotype
did not have an influence on clustering of the ISCs. Therefore,
we regressed out the genotype and reanalyzed the data. In low
dimensionality, we can observe that all ISC clusters are still
located together. For that reason, we can conclude that geno-
type did not influence clustering (Figure S5A). In addition, to
make sure that the ISC clusters we found are generally present
in mouse limb muscle, we integrated ‘‘FAPs’’ of the Giordani
data (n = 1,517) and ‘‘mesenchymal stem cells’’ of the Schaum
data (n = 1,127) together with our ISC data and observed perfect
overlap between the datasets (Figure S5B). ISC clusters still
localized together, which is also shown by the expression oftypical marker genes (Figures S5C and S5D). We reclustered
the data and were able to find clusters relating to ISC 1, ISC 2,
ISC 3a, and ISC 3b, although we did not find a cluster relating
to ISC 3c, which is expected because this cluster was specific
to dystrophic muscle (Figure S5E). In addition, there was one
ISC cluster that we did not find in our data as well as two more
distinct clusters: one we annotated as SCA-1 negative and the
other one as endothelial-like (Figure S5E). We checked the pres-
ence of cells from every dataset per cluster and were able to
observe cells from our dataset in the unannotated cluster (Fig-
ures S5F and S5G). This is most likely because of the low number
of cells in our dataset. In summary, we showed that ISC 3 con-
sists of three subtypes, all of which express subtype-specificCell Reports 31, 107597, May 5, 2020 5
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(A) PCA plot and k-means clustering (k = 5) of 125 ISCs. Every point represents a cell as ISC.
(B) Violin plot visualizing the expression of marker genes per ISC 3 cluster plotted. Expression is shown as log-normalized counts together with the median.
(C–E) Microscopy images of the skeletal muscle of healthy and dystrophic mice. ISCs are stained for PDGFRA (red), Hoechst 33258 (blue), and THBS4 (C),
CTHRC1(D), and PTX3 (E; all in green).
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(I) Bar plot showing the percentage of each ISC cluster in healthy and dystrophic muscle.
Scale bars, 50 mm. *p% 0.05; ***p% 0.001. See also Figures S4 and S5 and Tables S4 and S5.
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OPEN ACCESSmarker genes and are also present in other public datasets.
Moreover, we showed that these subtypes likely transition
from ISC 1 and ISC 2 to ISC 3 and that, in muscular dystrophy,
an ISC 3c population arises.6 Cell Reports 31, 107597, May 5, 2020Identification of an Interstitial Population that Controls
Adipogenesis
As these ISC groups did not relate to markers of dedicated
progenitor populations, we questioned whether there is an
100% CD142+
0% CD142+ 25% CD142+ 33% CD142+
50% CD142+ 66% CD142+
Oil Red O Hoechst
Oil Red O Hoechst PDGFRA
ACTA2 Hoechst
CD142+ CD142- CD142+/CD142-
C
D
14
2-
+241
D
C
Oil Red O Hoechst
CD142+ CD142- CD142+/CD142-
●●
●
●
●●
●
●
●
***
*
40%
60%
80%
100%
CD142+ CD142− CD142+/
CD142−
Fr
a
ct
io
n 
of
 P
DG
FR
A+
 c
el
ls
●
●●
●●●
●●●●●●
****
15%
30%
45%
60%
CD142− CD142+
Fr
a
ct
io
n 
of
 d
iff
e
re
n
tia
te
d 
ce
lls
●
●
●
●
●
●●
● ● ● ●●
●
●
●
●
●
●
●
●
● ●
●●
●
20%
40%
60%
0% 25% 50% 75% 100%
Percentage of CD142+ cells
Fr
a
ct
io
n 
of
 d
iff
e
re
n
tia
te
d 
ce
lls
●
●
●
●●
●
●
● ●
●
●
●
●
●
●●
●
●
●●
●●
●● ●
●
● ● ●
●●
●●
●
●
●●●
●
●
●● ●
●
Ad
ip
oq
Ce
bp
a
Pp
ar
g
0 4 12
0.00
0.04
0.08
0.12
0.0
0.1
0.2
0.3
0.4
0.00
0.01
0.02
Days in differentiation
Ex
pr
es
sio
n 
re
la
tiv
e
 to
 R
pl
13
a
● ●CD142− CD142+ *
*
*
*
*
F3
ISC 1 ISC 2 ISC 3
0
3
6
9
Lo
g(e
xp
re
ss
io
n)
* *
A B C
E
G
I J
ACTA2 Hoechst PDGFRA
CD142+
H
F
D
Adj. R² = 0.8518
P = 1.691e-12
Figure 4. CD142+ ISCs Inhibit Adipogenesis
(A) Expression of F3 (CD142) assessed by scRNA-seq. *p% 0.05.
(B) Microscopy images of CD142 and CD142+ after the induction of adipogenesis.
(C) Fraction of differentiated cells per population shown in (B) (n = 6).
(D) qPCR analysis of key adipogenic transcription factors during adipogenesis. Expression is relative to Rpl13a. Loess curve is fitted through data points; un-
certainty is displayed as 95% confidence interval (n = 3).
(E) Microscopy images of transwell assays with distinct ratios of CD142 (bottom) and CD142+ ISCs (top).
(F) Fraction of differentiated cells per ratio in (E) (n = 4).
(G) Microscopy images of transwell assays stained for Oil Red O (red) and PDGFRA (green).
(H) Fraction of PDGFRA+ cells per population shown in (G) (mean ± SEM; n = 3).
(legend continued on next page)
Cell Reports 31, 107597, May 5, 2020 7
Article
ll
OPEN ACCESS
Article
ll
OPEN ACCESSadipogenic function linked to any of the ISC clusters.
Recently, a cell population has been discovered in fat depots
that inhibits adipogenesis (Schwalie et al., 2018). These
Aregs comprise a population inside LINSCA-1+ cells from
subcutaneous stromal vascular fractions. By comparing the
top 200 marker genes, we found striking similarities,
especially for ISC 1 and ISC 2 (Figure S6A). In addition, we
could observe adipogenic genes, Pparg and Fabp4, in every
ISC cluster except for ISC 2 (Figure S6B). We sorted these
populations based on selected marker genes: Cd55 for ISC
1; F3 (encoding CD142) for ISC 2; and Sdc1 for ISC 3 (Figures
4A and S6C). We were able to sort for CD55 and CD142,
however, not for SDC1 (Figure S6D; data not shown).
When we subjected these sorted cell populations to an adipo-
genic differentiation assay in vitro, we observed a lack of
adipogenic response from CD142+ ISCs, although CD142
ISCs showed an increased adipogenic response compared
to bulk ISCs (Figures 4B and 4C). Furthermore, CD55+
ISCs showed a high adipogenic response, although the
adipogenic capacity of CD55 ISCs was lower compared to
bulk ISCs (Figures S6E and S6F). These observations were
confirmed by qPCR analysis of adipogenic genes (Figures
4D and S6G). Because of the opposite effects in adipogen-
esis that we observe between CD142+ and CD55+ ISCs, we
hypothesized that CD142+ ISCs inhibit adipogenesis. To vali-
date this hypothesis, we conducted a titration experiment,
seeding CD142 ISCs at the bottom and CD142+ ISCs at
the top of a transwell plate in different ratios. We observed
a negative linear relationship between adipogenesis in
CD142 ISCs and the amount of CD142+ ISCs (Figures 4E
and 4F). Thus, we can conclude that we found compelling
evidence for the existence of Aregs in the murine skeletal
muscle.
Next, we wanted to know whether the CD142+ cells kept the
CD142 ISCs in their progenitor state or pushed them toward
another cell fate. Therefore, we performed an adipogenic dif-
ferentiation of CD142, CD142+, and a transwell assay, seed-
ing CD142 ISCs (bottom) and CD142+ ISCs (top). After differ-
entiation, practically all CD142+ cells remained positive for
PDGFRA, although CD142 ISCs, which differentiate to adi-
pocytes, became negative for PDGFRA (Figures 4G and 4H).
When CD142 and CD142+ ISCs were incubated together,
we could clearly observe a decrease in adipocytes and an in-
crease in PDGFRA+ cells, marking progenitors (Figures 4G
and 4H). In addition, we could find a small number of
a-smooth muscle actin (ACTA2)+ cells, marking fibroblasts,
mostly in the CD142+ population (Figure 4I). These cells lost
PDGFRA expression during differentiation (Figure 4J). From
these results, we can conclude that, upon adipogenic differ-
entiation, CD142+ ISCs stayed nearly all PDGFRA+—although
a small fraction becomes positive for ACTA2—and that, when
incubated with CD142 ISCs, they are kept in a progenitor
state.(I) Microscopy images of transwell assays stained for ACTA2 (red) to indicate sm
(J) A microscopy image of transwell assays stained for ACTA2 (red) and PDGFRA
0.001. See also Figure S6.
8 Cell Reports 31, 107597, May 5, 2020A Deficiency of Adipo-regulatory Cells in Dystrophic
Muscle Is Directly Proportional to an Increased
Adipogenesis
Based on our scRNA-seq data, we found a vast reduction of
Aregs in dystrophic muscle. Therefore, we wondered whether
this results in an increased adipogenic potency of dystrophic
ISCs. Therefore, we isolated bulk ISCs (LINPDGFRA+SCA-
1+), CD142+ ISCs, and CD142 ISCs from the skeletal muscle
of healthy and dystrophic mice (Figures 5A and 5B). We could
validate the findings from our scRNA-seq experiment, as there
was a significantly lower number of CD142+ ISCs in dystrophic
mice (Figure 5C), and we observed an increased adipogenic
propensity in bulk dystrophic ISCs compared to healthy ISCs.
However, this difference was completely abolished when
CD142 ISCs and CD142+ ISCs were separated (Figures 5D
and 5E). Therefore, we conclude that the increased adipogenic
potency of ISCs from dystrophic muscle is linked to the
decreased ratio of CD142+/CD142 ISCs that is present in the
skeletal muscle of Sgcb-null mice.
To find out whether Aregs are not only restricted to murine
skeletal muscle, we isolated CD142+ and LIN ISCs from hu-
man skeletal muscle biopsies of healthy and dystrophic pa-
tients. Like in murine muscle, we observed a lower number of
CD142+ ISCs in the samples of dystrophic patients, compared
to healthy muscle biopsies (Figure 5F). Transwell assays with
CD142+ and CD142 ISCs incubated together with healthy
and dystrophic muscle in the insert resulted in an increased
adipogenesis in CD142 ISCs compared to CD142+ ISCs (Fig-
ures 5G, 5H, and S6H–S6J). In addition, we also tested the
myogenic commitment of human CD55+ ISCs and found that
these cells showed a higher myogenic propensity compared
to the CD55 ISCs in vitro and in vivo (Figures S6K and S6L).
In summary, we show that Aregs and CD55+ ISCs are present
in human skeletal muscle and are functionally similar to their
murine equivalent.
Aregs Suppress Adipogenesis via GDF10
To resolve themechanism by which Aregs exert their adipogenic
inhibition, our interest fell upon Gdf10, one of the highest-ex-
pressed markers of this population (Figure 6A). In addition, we
found that Gdf10 expression increased up to 5-fold in CD142+
ISCs during adipogenic differentiation (Figure 6B). We subjected
CD142+ ISCs to small interfering RNA (siRNA)-mediated Gdf10
reduction, lowering the expression ofGdf10 (Figure S7A) without
affecting cell viability (Figures S7B and S7C). A transwell assay
was performed with CD142 ISCs (bottom) and Gdf10-silenced
or scramble control CD142+ ISCs (top). Here, we observed an
increased adipogenesis of CD142 ISCs that were incubated
together with Gdf10-silenced CD142+ ISCs compared to
scramble control (Figures 6C and 6D). In addition, overexpress-
ing Gdf10 in CD142 ISCs (Figures S7D and S7E) resulted in a
decrease of adipogenic differentiation in CD142 ISCs (Figures
6E and 6F). From these results, we can conclude that GDF10ooth muscle cells/myofibroblasts.
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(E) Fraction of differentiated cells per population shown in (D) (n = 6).
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Figure 6. GDF10, Secreted by CD142+ ISCs,
Is Responsible for the Suppression of Adi-
pogenesis
(A) Expression of ISC 2 marker, Gdf10 (Bmp-3b)
determined by scRNA-seq (values represent log-
normalized counts). ***p% 0.001.
(B) Expression of Gdf10, relative to Rpl13a, in
CD142 and CD142+ ISCs during adipogenesis
(n = 3–6).
(C) Microscopy images of a transwell assay with
CD142 ISCs (bottom) co-cultured with CD142+
control or Gdf10 siRNA-transfected ISCs (top) after
the induction of adipogenesis.
(D) Fraction of differentiated cells per population
shown in (C) (n = 4).
(E) Microscopy images after the induction of adi-
pogenesis of CD142ISCs transduced with EGFP-
control or Gdf10-expressing lentivirus.
(F) Fraction of differentiated cells per population
shown in (E) (n = 3).
In (B), (D), and (F), t test, *p% 0.05; ***p% 0.001. In
all panels, nuclei are stained with Hoechst 33258
(blue) and lipids are stained with Oil Red O (red).
Data are represented as mean ± SEM. Scale bars,
50 mm. See also Figure S7.
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OPEN ACCESSplays a substantial part in the ability of skeletal muscle Aregs to
suppress adipogenic differentiation.
In vivo, GDF10 is highly present in themuscle of wild-typemice
although this abundance is decreased in dystrophic mice (Fig-
ure 7A). Therefore, we wanted to investigate the importance of
GDF10 in vivo. We injured five wild-type and five Gdf10/
mice (Zhao et al., 1999) through a glycerol injection in the tibialis
anterior. The contralateral leg was used as a control (saline in-
jected). After 2 weeks, an increased fibrosis was seen upon
injury, irrespective of the presence of GDF10 in the skeletal mus-
cle (Figures 7B and 7C). However, the amount of fat deposition
increased in the Gdf10/ compared to the wild type in both
the saline- and glycerol-injected muscles (Figures 7D and 7E).
This suggests that the absence of GDF10 leads to an increase
of fat depots within the skeletal muscle.
DISCUSSION
Interstitial cells are frequently implicated in skeletal muscle dis-
orders (Lemos et al., 2015; Mozzetta et al., 2013; Mueller et al.,
2016; Saccone et al., 2014). However, it is still debated whether
skeletal muscle regeneration is mediated only by a dedicated
population of stem cells, namely MuSCs, or whether the intersti-
tial cells actively participate tomyogenesis.We and other groups
provided evidence that the ISCs are therapeutically useful in
stem-cell-based treatments (Judson et al., 2018; Mitchell et al.,
2010; Pe´rie´ et al., 2014; Sampaolesi et al., 2003, 2006). However,
the use of marker-based approaches to analyze heterogeneous
cell populations makes it difficult to accurately define interstitial
populations. This generated a partial overlap among the different
cell types in terms of shared markers and functions. In order to
clarify whether these different cell types could be analogous or
at different differentiation stages, there is an urgent need to
distinguish the different populations of the muscle interstitium.
In this direction, a recent study of singe-cell qPCR on FAPs re-10 Cell Reports 31, 107597, May 5, 2020veals interesting information regarding the differential expres-
sion levels of Tie2 and Vcam1 in response to an acute injury or
in a dystrophic environment (Malecova et al., 2018). However,
the use of biased markers to isolate single cells limited the infor-
mation and does not provide a full picture of the entire muscle
interstitial cell composition. Another study provided clear infor-
mation regarding the main cell population in healthy skeletal
muscles using 10X Genomics and cytometry by time of flight
(CyTOF) approaches (Giordani et al., 2019). However, it did not
assess the heterogeneity of SCA-1+ ISCs and did not consider
the consequence of pathological conditions on the cellular
landscape.
Our single-cell transcriptomics-based approach overcomes
many of these complications and unveils at least three popula-
tions in the interstitial progenitor pool of the skeletal muscle.
Although all ISCs could be annotated as FAPs, we showed
that there is more heterogeneity inside this population and that
MABs belong to the ISC 2 and ISC 3 population. Furthermore,
we demonstrate that there is more resemblance between
these two populations as previously thought, which urges us to
look differently to interstitial progenitor heterogeneity. One pop-
ulation that we describe consisted of CD55+ cells (ISC 1) that are
enriched for TGF-b signaling GO terms (Table S2). ISC 1 also
expressed the highest levels of stemness markers Ly6a and
Cd34 and retained high adipogenic potency in vitro. ISC 2 was
characterized by F3 and Gdf10 expression and can block
adipogenesis by paracrine signaling, of which GDF10 is an
important secreted factor. It has been suggested that GDF10
acts through the TGF-b pathway in cancer cells (Upadhyay
et al., 2011). Furthermore, Platko et al. (2019) showed that perox-
isome proliferator-activated receptor g (PPARg) is antagonized
by GDF10 in hepatocytes through the TGF-b/SMAD3 pathway.
More research will be necessary to find out whether ISC 2
controls adipogenesis via the same mechanism. ISC 3 is a
more heterogeneous population and is characterized by the
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Figure 7. GDF10 Suppresses In Vivo Adipo-
genesis
(A) Microscopy images of the skeletal muscle of
healthy (C57Bl6) and dystrophic (Sgcb-null) mice
stained for GDF10 (red).
(B and D) Microscopy images of the skeletal
muscle of healthy (C57Bl6) and dystrophic (Sgcb-
null) mice 2 weeks after intra-muscular injection
with either saline or glycerol. Sections were
stained for fibrosis using a-smooth muscle actin
(ACTA2, red; B) and adipocytes using oil red O
(red; D).
(C) Fraction ACTA2+ cells shown in (B) (n = 5–6).
(E) Fraction of oil red O+ cells shown in (D) (n = 5–6).
In (C) and (E), *p < 0.05; **p < 0.01. In all panels,
nuclei are stained with Hoechst 33258 (blue). Data
are represented as mean ± SEM. Scale bars,
200 mm.
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OPEN ACCESSexpression of Thbs4. In dystrophic muscles, ISC 3 contains
three clusters that express specific genes like Ptx3, involved in
acute inflammation (Bottazzi et al., 2016), and Cthrc1, which is
important in tissue remodeling (Wu et al., 2017). Moreover, pseu-
dotemporal ordering of interstitial cell populations conceded a
theoretical transitioning pattern between ISC 1, ISC 2, and ISC
3, as well as a shift from healthy to dystrophic muscle. ISC 3
could be heavily affected by the loss of tissue homeostasis
and potentially dictates the disastrous changes during muscle
degeneration. In summary, we disentangled the heterogeneity
of skeletal muscle interstitial cells in pathophysiological condi-
tions and found evidence that one specific population could be
responsible for blocking aberrant fat deposition.
Within the adipogenesis, PPARg has been identified as the
master regulator. Therefore, inhibiting PPARg is essential in or-
der to block adipogenesis within the skeletal muscle, indirectly
suggesting an effect of GDF10 on PPARg. Contradictory to its
role in fat accumulation, PPARg is also important for mitochon-
drial biogenesis, switching to oxidative fiber types, myogenesis,
and angiogenesis, all contributing to better muscle performance(Amin et al., 2010; Phua et al., 2018).
Thus, although GDF10 can reduce the
replacement of myofibers with adipose
tissue, it should be noted that it might
also have a negative effect on the muscle
function itself.
Furthermore, as PPARg is considered a
master regulator, its expression is
controlled through multiple mechanisms,
including hedgehog, Wnt/b-catenin, and
bone morphogenesis protein (BMP)-
mediated signaling pathways (Du et al.,
2010; Platko et al., 2019; Yao et al.,
2019). From our data, it is likely that
GDF10 acts through one of these mecha-
nisms, as the overexpression of GDF10
does not fully block adipogenesis. Within
the CD142+ ISCs, GDF10 most likely
works together with other factors toinhibit PPARg completely and thus the adipogenic differentiation
of CD142 ISCs. Nevertheless, GDF10 absence in the Gdf10/
mice resulted in fat depots within skeletal muscles that can be
exacerbated by glycerol treatment. These in vivo results fully
support the critical role of GDF10 in controlling aberrant fat
depots in muscle tissues.
It remains to be determined how this interstitial remodeling
takes place in dystrophic skeletal muscle and what the driving
factors are. In recent light, a similar CD142+ cell population
that is essential for colonic epithelial stem cell functionwas found
to be highly reduced in colitis, suggesting its broad implications
in tissue homeostasis (Kinchen et al., 2018). We hypothesize that
inflammation could be an essential factor of this remodeling,
which suggests an important role for immune cells. We know
that ISCs can be affected by the immune system because it
was shown that macrophages, by secreting TGF-b, are able to
inhibit the apoptosis of FAPs in muscular dystrophy (Lemos
et al., 2015).
Taken together, our results shed light on the interstitial cell
types of the murine skeletal muscle in health and chronic muscleCell Reports 31, 107597, May 5, 2020 11
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OPEN ACCESSinjuries and provide evidence that there is a cell population that
inhibits adipogenesis. We hypothesize that the fact that this pop-
ulation is reduced in dystrophic muscle could be a potential
cause for aberrant fat deposition that arises in patients with
muscular dystrophy, although further research is necessary to
be able to provide a causal link. Nevertheless, these findings
are a potential explanation and might aid in developing future
therapeutic approaches that block adipogenesis in the skeletal
muscle and prolong the ambulation of muscular dystrophy
patients.
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Mice
All mouse experiments were conducted in strict accordance with European law and were approved by the Animal Ethics Committee
of KU Leuven (P150/2014 and P169/2017). All mice were kept in specific pathogen-free conditions in individually ventilated cages.
Themouse strains used were C57BL/6J and C57BL/6J Sgcb/ and C57BL/6JGdf10/mice. All mice used in these experiments
were male and between four and eight weeks old, unless specified otherwise. For lineage tracing studies, C57BL/6J Alpl-Cre were
crossed with C57BL/6J R26-YFP. Afterward, cells from the hindlimbs were collected at two, five and eleven weeks of age (n = 4-8).
Human samples
Humanmale skeletal muscle biopsies were obtained from healthy (n = 3) andDMD (n = 3) subjects (ranging 14–35 years of age) during
elective orthopedic surgery performed at the Department of Orthopedic Surgery of the Istituto Ortopedico Galeazzi IRCCS Milan
Italy, after patient informed consent.
Cell lines
All cultured cells were isolated from male mice and cultured in high glucose DMEM medium supplemented with 20% fetal bovine
serum (FBS), 10% Horse serum (HS) and 1% penicillin-streptomycin (pen-strep, all from GIBCO) (Growth Medium) on collagen-
coated plates (Sigma-Aldrich). Cells were kept in a humified incubator under hypoxic conditions (5% O2, 5% CO2 and 37
C).
METHOD DETAILS
Isolation and digestion of hindlimbs
Tissue collection was carried out in accordance with the protocol published by Liu et al. (2015) with small alterations. In short, all
hindlimb muscles were isolated by surgical dissection and finely minced. Minced muscles were digested with Collagenase II
(Sigma-Aldrich, 700-800 U/ml in PBS) supplemented with 10% HS, 25 mM CaCl2 and 100 U/ml pen-strep (all from GIBCO), for
90 min at 37C in a warm water bath with agitation (60-70 rpm). At 60 and 90 min, the tissue was homogenized with an 18 and
20-gauge needle, respectively. Next, a red blood cell lysis was performed by incubating the cell pellet in the red blood cell lysis buffer
(154 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) for 5 min, followed by a PBS wash, filtration through a 40 mm cell strainer (Corning)
and centrifugation for 5 min at 400 g at 4C.
scRNA-seq
Library preparation
LIN- muscle cells were sorted single-cell by FACS in 96 well plates (4titude). Each well contained 4 ml lysis buffer (0.4% Triton X-100 in
RNase-free water supplemented with 10 mM biotinylated Oligo-dT (IDT), 10 mM dNTPs (Thermo Scientific) and 0.5 U/ml RNase in-
hibitor (Takara)). cDNA libraries were generated based on the SMART-seq2 protocol (Picelli et al., 2014). Briefly, before mRNA was
reverse transcribed, lysed cells were incubated at 72C for 3 min and cDNA was amplified via PCR for 22 cycles. Amplification was
done with KAPA HIFI Hot Start ReadyMix and purification by magnetic beads. Quantity and quality of cDNA were assessed with a
Qubit fluorometer (Thermo Scientific) and Agilent 2100 BioAnalyzer with a high-sensitivity chip, respectively. Library preparation
was done with the Nextera XT library prep and index kit. 100 pg of cDNA was tagmented by transposase Tn5 and amplified with
dual-index primers (i7 and i5, 14 cycles). Reagents were mixed together by the Echo 555 (Labcyte) and pooled Nextera XT libraries
were purified. 384 single-cell libraries were pooled together and sequenced single-end 50 bp on a single lane of a Hiseq2500 or Hi-
Seq4000 (Illumina). All results related to scRNA-seq are based on freshly isolated muscle cells from C57Bl6 (healthy cells, n = 115)
and Sgcb null (dystrophic cells, n = 141) mice, experiments were performed on the same day.
FACS isolation of the interstitial stromal cells
The single-cell suspension was diluted to 13 106 cells/ml with FACS buffer (2%FBS, 10mMHEPES and 10mMNaN3 at a pH of 7.2).
Cells were incubated with the primary antibodies 30 min at 4C protected from light. The following antibodies were used: TER-119-
FITC (0.5 mg/106 cells), CD31-FITC (0.25 mg/106 cells) and CD45-FITC (0.25 mg/106 cells) for selecting the LIN- population; SCA-1-
SB436 (0.5 mg/106 cells) and/or CD140a-APC (1 ml/106 cells) to enrich for ISCs, ALPL-PE (0.25 mg/106 cells) to enrich the LIN-
population for MABs, Itga7-PE-Vio770 (0.15ng/106 cells) and CD34-eFluor660 (2.5 mg/106 cells) to enrich for MuSCs; CD55-PE
(0.5 mg/106 cells) and CD142-PE (2 ml/106 cells) to separate the ISC populations. The cells were washed twice and stained with
SYTOX green dead cell stain (1ml/ ml) to assess viability. The analysis was performed on a BD FACSCanto II HTS (BD Biosciences).
Sorting was performed on the BD FACSAria III (BD Biosciences), using a 100 mm nozzle at 18 PSI or on the BD FACSMelody (BD
Biosciences), using a 100 mm nozzle at 22 PSI (n = 3-4). Compensation measurements were performed for single cell stains with
UltraComp eBeads compensation beads (Invitrogen #01-2222-41). Data were collected with the FacsDIVA software and analysis
was performed using FlowJo software.Cell Reports 31, 107597, May 5, 2020 e3
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Murine interstitial stromal cells
The same number of cells was sorted and seeded into flat-bottom 24 well cell culture plates (Corning #3738) coated with Collagen
(Sigma-Aldrich). For adipogenic differentiation cells, we used the StemPro Adipogenesis Differentiation kit with medium changes
every 3 to 4 days. Differentiation was carried out for 10 to 12 days after induction at which point the cells were stained for imaging
or collected for RNA isolation. For myogenic differentiation cells MAB, FAP and MuSCs (transduced with GFP transgenic MLV viral
vectors (3.325 3 106 TU/ml)) were mixed with control MuSCs at a 1:2 ratio in growth medium. The culture was carried out for 3 to
4 days after induction.
For the human ISCs, 53 103 CD142+ andCD142- ISCswere sorted from healthy (n = 3) andDMD (n = 3)muscles and co-cultured at
the bottom chamber of the transwell. For myogenic differentiation, after seeding cells on a laminin-coated surface, serum-starvation
was performed for five days.
Quantification of ex vivo differentiation
Differentiated cells were fixed with 4% paraformaldehyde before staining with Hoechst33342 (Sigma-Aldrich #14533), Oil Red O
(Sigma-Aldrich) and Perilipin-1 A/B (1:100) with secondary antibody anti-rabbit AF488 (Sigma-Aldrich #SAB4600234) (n = 3). Image
analysis was performed in ImageJ/Fiji, lipid droplets (red) and nuclei (blue) images were filtered using a Gaussian blur (sigma equal to
2) before automatic thresholding. For myogenic differentiation, cells were stained with Hoechst33342, Desmin (1:100), and MF20
(1:20). Fluorescence images were acquired via Eclipse Ti inverted microscope (Nikon).
In vivo experiments
Myogenic differentiation potential of ISCs
53 106 CD55+ (n = 5) and CD55- (n = 5) ISCs in 8 ml of HBSS (GIBCO) were transplanted in the Tibialis anterior of Sgcb/mice. The
grafted muscles were harvested five weeks after transplantation and were snap frozen in liquid nitrogen. Serial transverse 12 mm
cryostat sections were obtained from cell injected muscles and stained for human SGCB (1:50) and LAMININ (1:100).
Effect of GDF10 upon injury
C57BL/6 and C57BL/6 Gdf10/ mice (n = 5) were injected with 50 ml of 50% glycerol in the right Tibialis anterior, the contralateral
muscle was injected with an equivalent amount of PBS. The muscle was harvested two weeks after injury and snap frozen in liquid
nitrogen. Serial transverse 8 mm cryostat sections were obtained made and stained for ACTA2 (1:200) or Oil red O and LAMININ
(1:100).
Transwell titration experiment
CD142- ISCs were seeded at the bottom of a 24w transwell plate at 10,000 cells/cm2 and CD142+ ISCs in the top insert at different
ratios (ranging from 5,000 to 30,000 for the titration experiment and 20,000 for other transwell experiments). Cells were differentiated
as described above (n = 4).
siRNA-mediated knockdown of Gdf10
For Gdf10 silencing, a pool of two siRNA probes (#98, #99; Thermo Scientific #1320003) was reverse-transfected to CD142+ ISCs
(Figure S7). 10,000 cells/cm2 were plated with 100 nM of siRNA dissolved in 1.5% Lipofectamine RNAi MAX (Invitrogen) in Opti-
MEM I reduced serum medium (Invitrogen). After 8 hours, the medium was changed normal growth medium and after 12 hours
the cells were collected for determining knockdown efficiency, seeded in collagen-coated 24well plates at a density of 10,000
cells/cm2 or seeded in collagen-coated 24well transwell inserts together with CD142- ISCs at the bottom. After 48 hours, all cell pop-
ulations were treated with adipogenic differentiation medium (n = 4).
Viral vector-mediated overexpression of Gdf10
ForGdf10 overexpression, CD142- ISCs were plated 10,000 cells/cm2 in growth medium together with MLV-based vectors express-
ing Gdf10 (MLV_EF1a-Gdf10-myc) or a control vector (MLV_SF-eGFP). After 48 hours, cells were collected for determining overex-
pression efficiency or subjected to adipogenic differentiation and imaged at day 10 after induction (n = 6).
RNA isolation and quantitative PCR
RNA isolation of sorted and differentiated cells. Live cells were collected in RLT lysis buffer (QIAGEN) and snap frozen on dry ice.
Cell lysates were homogenizedwith 21G syringes before RNA isolation using the RNeasy PlusMicro Kit (QIAGEN). Reverse transcrip-
tion was performed using the Superscript III reverse transcriptase (Invitrogen), following the manufacturer’s recommendations.
Expression levels of mRNA were assessed by real-time PCR using the Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen)
on the fast run mode of the Viia7 Real-Time PCR system (Thermo Scientific). mRNA expression was normalized to Rpl13a (for all
mouse experiments, if not otherwise specified) (n = 6).e4 Cell Reports 31, 107597, May 5, 2020
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scRNA-seq data analysis
Fastq files contained 50-bp-long single-end sequenced tags (reads) from 384 cells each were trimmed with cutadapt 1.5 (Martin,
2011). The number of tags per gene was calculated using htseq-count 0.6.0 (Anders et al., 2015). Quality control on aligned and
counted reads was done with Scater 1.8.4 (McCarthy et al., 2017), cells with < 150,000 reads; < 1,500 detected genes; > 6% mito-
chondrial DNA and > 10% of spike-in ERCCs (Figure S1B). Cell cycle selection and read normalization were done with Scran 1.8.4
(Lun et al., 2016), cells were selected for G1 cell cycle phase and reads were normalized separately from ERCCs with parameters
‘min.size = 30’ (Figure S1C). For each gene, expression estimates per gene were expressed as log-transformed counts by taking
the log2(counts + 1). We used the top 500 highest variable genes to obtain a 2D representation of the cells while maintaining the
similarity relationships between them using t-SNE (van derMaaten andHinton, 2008) with a perplexity of 6. Clustering was performed
with SC3 1.8.0 (Kiselev et al., 2017) using k = 7 (Figures S1E–S1G). Differential expression between clusters was calculated using
the nonparametric Kruskal–Wallis test, p < 0.01 corrected for multiple testing with a Benjamini-Hochberg False Discovery Rate
(FDR) correction (Tables S1 and S4). Marker genes were selected by a binary classifier for each gene that was constructed based
on the mean cluster-expression values. The area under the receiver operating characteristic (AUROC) curve was used to quantify
the accuracy of the prediction. A P-value was assigned to each gene using the Wilcoxon signed-rank test, comparing gene ranks
in the cluster with the highest mean expression with all others. Genes with AUROC > 0.85 and with p < 0.01, were defined as marker
genes. Heatmaps were generated using pheatmap_1.0.10 with marker genes filtered for AUROC > 0.8 and adjusted P-value < 0.01
(Wilcoxon signed-rank test, holm correction).
For further analysis of ISCs, we additionally removed cells with > 6% of spike-in ERCCs (Figure S6C). Clustering on ISCs was per-
formed with SC3 1.8.0 (Kiselev et al., 2017) using k = 5. Consensus, silhouette analysis and well-known marker genes supported a
five-partitioning clustering (Figures S6D–S6F). We used PCA on the top 500 most variable genes to visualize the distinction between
the clusters. Differentially expressed andmarker genes between clusters were calculated with SC3 asmentioned above. Regressing
out the genotype was done with Seurat 3.1. SCEset object was converted to a Seurat object and the scaledata function was used to
regress out cell genotype (Figure S5A). The pseudotime and BEAM analysis were done with Monocle2 2.12.0 (Trapnell et al., 2014)
with selected genes based on DE (standard Wilcoxon test with Holm correction) of SC3 clusters. For the pseudotime analysis a
minimum spanning tree was constructed of healthy and dystrophic ISCs based on the expression pattern of 1000 genes with the
first two dimensions of PCA on k-means clusters (k = 5). BEAM analysis fitted a negative binomial generalized linear model (GLM)
from the ISC 2 branch to ISC 1 and ISC 3 (Figures S6K and S6L). The RNA velocity analysis was performed using velocyto. We filtered
genes with a minimum average expression count lower than 0.05, fit gammas on the top/bottom 10% quantiles based and used the
20 k-nearest-neighbors in slope calculation smoothing (Figure 3F).
scRNA-seq data analysis of public datasets
scRNA-seq data of healthy murine skeletal muscle from Giordani et al. (2019) (n = 12,441) was downloaded from the NCBI Gene
Expression Omnibus database (GEO, GSE110878’). The data was reanalysed with Seurat 3.1. Cells with more than 10% mitochon-
drial DNA were removed. Further, counts were log-normalized, the 2000 most variable features selected, data was scaled and 20
PCA dimensions were taken to perform clustering at a resolution of 0.5 and UMAP dimensionality reduction. Differential expression
analysis was done by a Wilcoxon test, selected genes were at least expressed in 25% of the cells in each cluster and had a logFC
treshold of 0.25. Cell type annotation was done by the following marker genes: CD3g (T); CD79a (B); CD14 (Monocyte); CD14, IL1b
(Macrophage); Retnlg (DC), Pecam1 (endothelial), Ly6a, Pdgfra (FAP),Myod1 (satellite),Myl9 (SMMC), Thbs4 (Tenocyte), Plp1 (Glial)
(Figure S2C). scRNA-seq data from the Tabula Muris Consortium (Schaum et al., 2018) was downloaded through the ExperimentHub
package and filtered for limb muscle data (n = 4,543), cell annotation was provided by the authors. Analyzing the percentage of
matching markers was done by calculating the amount of DE genes that were found per cluster in our dataset compared to the Gior-
dani or Schaum dataset, divided by the total amount of marker genes per cluster defined in our data (Figures S2E and S2F). Integra-
tion of all datasets was done by canonical correlation analysis (CCA) with Seurat 3.1. All datasets were merged into one Seurat
object, data was normalized, the 2000most variable features were selected, and integration anchors were defined for 30 dimensions
(Figures S2G–S2I). For integration of all ISC clusters, we selected the ‘FAP’ cluster of the Giordani data (n = 1,517) and the ‘mesen-
chymal stem cell’ cluster of the Schaum data (n = 1,127). Integrating all datasets was done in the same way as for the limb muscle
data with the only difference that we used 10 dimensions to integrate anchors (Figures S5B–S5G).
Annotation and functional enrichment analyses
Enrichment analysis was performed for DE genes for LIN- and ISC clusters (Table S1) using the web server Enrichr with default
parameters (Kuleshov et al., 2016) and annotations provided by GO cellular biology (Ashburner et al., 2000; Carbon et al., 2017),
Wikipathways (Slenter et al., 2018), or gene expression data provided by the GTEx project (GTEx Consortium, 2015) and ARCHS4
tissues (Lachmann et al., 2018) (Tables S2, S3, and S5). The combined score value is computed by multiplication of the log p-value
from the Fisher’s exact test by the z-score of the deviation from the expected rank.Cell Reports 31, 107597, May 5, 2020 e5
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All t tests and Wilcoxon rank-sum tests were unpaired and two-sided, if not otherwise specified. All boxplots were generated
and displayed in R, using the geom_boxplot() function of ggplot2 with default parameters. The median value is indicated with a
black line, and a colored box (hinges) is drawn between the 1st and 3rd quartiles (interquartile range, IQR). The whiskers correspond
to approximately 1.5x interquartile range (±1.58 interquartile range divided by the square root of n) and outliers are drawn as
individual points. All violin plots are generated and displayed in R, using the geom_violin() function of ggplot2. Individual points or
median value is portrayed by a point. All bar plots display mean values as centers and the standard deviation as error bars. All
included microscopy images and macroscopic images are representative.e6 Cell Reports 31, 107597, May 5, 2020
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Figure S1: Quality control and gene set enrichment of single-cell RNA sequencing from 
healthy and dystrophic skeletal muscle (Related to Figure 1) 
a, Number of isolated cells after hindlimb digestion of one-month-old healthy and dystrophic 
mice. * P ≤ 0.05. b, Quality control of scRNA-seq data with cut-offs for aligned reads/cell, 
detected genes per cell, percentage of mitochondrial genes, percentage of ERCCs. c, Cell-cycle 
phase per genotype, h: healthy, d: dystrophic. d, Box plot of ubiquitous (Actb), endothelial 
(Cd31, Kdr and Cdh5) and haematopoietic markers (Cd45, C-kit, Flk2), values shown as log-
normalised counts. e-g, Quality control measures of k-means clustering, consensus matrix (e), 
silhouette plot (f) and stability index (g). h, Top 10 marker genes per cluster ordered by 
AUROC. i, Top 5 GO biological processes, wikipathways, ARCH4S and GtEX tissues 
significantly enriched among DE genes per cluster. j, t-SNE plot of 256 cells from healthy and 
dystrophic murine muscle every point represents one cell. k, Bar plot showing percentage per 
cluster per genotype, cluster-specific cell counts visualised in the bar. AUROC: area under 
receiving operator characteristic.  
  
Figure S2: Integration with public scRNA-seq data (Related to Figure 1) 
a, Boxplot of sequencing metrics (total detected genes per cell and log(total counts) per cell) 
comparing our interstitial scRNA-seq data (n=256), represented as Camps with scRNA-
seq data of the murine limb muscle by Giordani et al. (n=12,441) and Schaum et al. 
(n=4,543). b-c, Cell type annotation of Giordani data. Clustering visualisation on UMAP 
dimensionality reduction. (b). Dotplot visualising top markers per cell type, average 
expression respresented by colour and percentage of expression by size (c). d, Cluster 
annotation, provided by authors, visualised on UMAP dimensionality reduction 
of Schaum dataset. e-f, Marker genes comparison, showing the percentage of matching markers 
per cell type of our dataset with the Giordani (e) and Schaum (f) dataset. g-h, Unsupervised 
integration of Camps, Giordani and Schaum datasets. UMAP visualisation (n=17,240) shows 
that there is no batch artefact after integration. (g). UMAP visualisation of cell type annotation 
per cluster split per dataset demonstrates matching clusters between the datasets (h). i, 
UMAP visualisation of integrated datasets with corrected cell type annotation based on h. For 
b, d , g-i: every point represents one cell.  
 
 
 
 
 
Figure S3: scRNA-seq analysis of satellite cells and lineage tracing of 
ALPL+ cells (Related to Figure 2) 
a, k-means clustering of MuSCs form healthy and dystrophic muscle (n=40). PCA plot with 
SC3 clusters (k = 4) annotated as colour. b, Minimum spanning tree of healthy and 
dystrophic MuSCs based on the expression pattern of 243 genes with the first two dimensions 
of PCA on k-means clusters (k = 4). The solid black line represents the pseudotime ordering. c-
d, Violin plot visualising essential myogenic transcription factors (c) and marker genes of the 
dystrophic activated cluster (d) as log-normalised counts per MuSC cluster. e-f, Violin 
plot visualising essential myogenic transcription factors (e) and marker genes of the dystrophic 
activated cluster (f) as log-normalised counts of skeletal muscle satellite cells of the limb 
muscle from the Tabula Muris Consortium scRNA-seq data (n=354). g, Flow cytometry 
images of SCA-1 (Superbright 436) and ALPL (YFP) of LIN-(CD31-CD45-TER-119-) cells 
isolated from hindlimbs of Alpl-Cre-R26-YFP mice. h, Quantification of SCA-1+ cells in 
ALPL-YFP+ population (n=4-8). *P ≤ 0.05. For a-f: every point represents one cell.  
  
   
 
 
Figure S4: Quality control, gene enrichment and trajectory analysis of single-cell RNA 
sequencing of ISCs (Related to Figure 3) 
a-b, Gene expression visualised as log-normalised counts on t-SNE plot (n=125) of healthy and 
dystrophic muscle (a) and box plot per ISC cluster (b). c, Quality control of scRNA-seq data 
with cut-offs for aligned reads/cell, detected genes per cell, percentage of mitochondrial genes, 
percentage of ERCCs. d-f, Quality control measures of k-means clustering. Consensus matrix 
(d), silhouette plot (d) and stability index (f). g, Bar plot comparing ISC cluster annotation to 
previous annotation in all LIN- cells. h, Bar plot of genotype fraction per ISC 
cluster. i, Pseudotime ordering of ISCs on a minimum spanning tree. j, Top 5 GO biological 
processes, Wikipathways and GtEX tissues that are significantly enriched among DE genes per 
cluster. k, Branched expression analysis modelling (BEAM) on branch-dependent expressed 
genes between ISC states. Solid lines represent ISC 2 to ISC 1 trajectory, dashed line represents 
ISC 2 to ISC 3 trajectory. Negative binomial GLM, ***: adjusted p-value < 0.0001. For a, i, k, 
l: every point represents a single cell.  
 
   
Figure S5: Integration of ISCs with public scRNA-seq data (Related to Figure 3) 
a, UMAP visualisation of ISC clusters with genotype regressed out. b-d, Integration of ISCs 
(n=114) represented as Camps together with ISCs from two public datasets from Giordani et 
al. (n=1,517) and Schaum et al. (n=1,127), represented as Giordani and Schaum respectively. 
UMAP visualisation (n=2,758) shows that there is no batch artefact after integration (b). c, 
Gene expression of important ISC markers visualised on UMAP coordinates. d, Graph-based 
clustering on integrated ISC data, annotations based on marker genes and the localisation of the 
ISC cluster from Camps dataset on the UMAP coordinates. f, Cell count per cluster grouped by 
dataset. g, Gene expression of ISC marker genes visualised on UMAP coordinates. d and g: 
gene expression levels visualised as log-normalised counts. Every point represent a single cell. 
UMAP: uniform manifold approximation and projection.  
 
 
  
Figure S6: CD55- ISCs show an inferior adipogenic differentiation capacity (Related to 
Figure 4 and 5) 
a, Number of overlapping markers between ISCs and stromal clusters found in LIN-SCA-
1+ cells of subcutaneous stromal vascular fractions by Schwalie et al. b, Expression (as log-
normalised counts) of adipogenic genes Pparg and Fabp4, as determined by scRNA-seq. c, 
Expression (as log-normalised counts) of Cd55, F3 and Sdc1 determined by scRNA-seq. 
***P ≤ 0.001. d, FACS-based sorting strategy to isolate ISC 1 and ISC 2 populations. e-
g, Adipogenic differentiation of CD55- and CD55+ ISCs. e, Immunostaining images: Hoechst 
33258 (blue), PERILIPIN-1 (green) and Oil red O (red). Scale bar = 50 µm. f, Percentage of 
PERILIPIN-1+ cells. g, qPCR analysis of stemness and adipogenic markers, expression as Delta 
CT, normalised to Rpl13a, Rab35 and Gapdh. h, Microscopy images of CD142+ and 
CD142- ISCs isolated from skeletal muscles of healthy human subjects after the induction of 
adipogenesis. PERILIPIN-1 (green), FABP4 (red) and Hoechst (blue). i-j, Fraction of 
differentiated cells per population as shown in h, stained for PERILIPIN-1 (i) and FABP4 
(j) (n=3). k, Representative microscopy images of CD55+ and CD55- ISCs differentiated in 
myogenic condition. MyHC (red), DESMIN (green) and Hoechst (blue) (n=3). l, Localisation 
of SGCB (red) and LAMININ (green) in Sgcb-null muscles transplanted with CD55+ and 
CD55- ISCs (n=5). In e-g (n=3). Scale bars, 50 µm and 200µm. *P ≤ 0.05, **P ≤ 0.01.  
 
 
 
Figure S7: Quality control of Gdf10 silencing and overexpression (Related to Figure 6) 
a, Expression of Gdf10, relative to Rpl13a, in CD142+ ISCs after transfection 
with Gdf10 or scramble siRNA. b-c, Viability assessment of CD142+ ISCs after transduction 
with Gdf10 siRNA through flow cytometry analysis with 7AAD (b) and Calcein blue (c). 
Unstained sample as control (n=3). d, Expression of Gdf10, relative to Rpl13a, in CD142- ISCs 
after transduction with Gdf10-myc or eGFP control viral vectors. e, western blot for MYC of 
transduced CD142- ISCs in d.  
 
